Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0ZY4C
|
||||
| Former ID |
DNC014364
|
||||
| Drug Name |
N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530923] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H20N4
|
||||
| Canonical SMILES |
C1CCN(C1)C2=NC=CC(=N2)NCCC3=CC=CC=C3
|
||||
| InChI |
1S/C16H20N4/c1-2-6-14(7-3-1)8-10-17-15-9-11-18-16(19-15)20-12-4-5-13-20/h1-3,6-7,9,11H,4-5,8,10,12-13H2,(H,17,18,19)
|
||||
| InChIKey |
MIALFBONYMMUFB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [530923] | |
| Cholinesterase | Target Info | Inhibitor | [530923] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.